ICON plc en las noticias
Consultoría y servicios de desarrollo de fármacos
Tamtam encontró 20 artículos recientes sobre ICON plc.
- ICON PLC (ICLR) Is Leveraging AI to Accelerate Clinical Trials
- U.S. Markets Rose Wednesday; Icon PLC Topped Leaders
- Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
- Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
- Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR
- BofA Securities Upgrades Icon PLC (ICLR) to Neutral, Lifts Price Target Amid Positive CRO Outlook
- ICON plc Stock 12‑Month Price Target Raised to $187.81, Implies 14% Upside
- Results arrive after market close October 27 for ICON (ICLR), with an earnings call October 28.
- Is Icon PLC (ICLR) a Bargain After 3.9% Drop? GF Value Says Unde
- ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings
- S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag
- White & Case advises ICON on its US$2.15 billion notes offering and related secured debt refinancing
- Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
- ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity
- Icon PLC (ICLR) Lags Q2 Earnings Estimates
- Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?
- Icon defends claim it left investors with ‘billions in losses’
- Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline
- ICON plc Selects Microsoft (MSFT) As Preferred Technology Partner
- Greenskeeper Asset Management Increased Its Holdings in ICON Plc (ICLR) Amid Market Fear
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como ICON plc?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares